Quantcast

Latest Oncology Stories

2014-07-01 08:29:13

ORCA(TM) program includes seven Phase 2 trials in tumor types where patient need is acute, including bladder, lung, pancreas and prostate cancers BOTHELL, Wash. and VANCOUVER, British Columbia, July 1, 2014 /PRNewswire/ -- OncoGenex Pharmaceuticals, Inc. (NASDAQ: OGXI) today announced initiation of the Cedar(TM) clinical trial, an investigator-sponsored, randomized, open-label Phase 2 trial evaluating apatorsen in previously untreated patients with advanced squamous cell lung cancer....

2014-06-30 23:22:45

Oncologists come in many different forms. When a litigator requires an oncology expert witness, there are several questions to ask. Mednick Associatesshares the outline of their search process. Wilton, CT (PRWEB) June 30, 2014 Legal cases involving oncology matters are bound to be emotionally straining for both the plaintiff and defendant. Since most people know someone who has battled with cancer, professional opinions on oncology cases can easily stray from objective to subjective. As...

2014-06-30 23:15:06

The audit of the 2013 financials revealed that the Mesothelioma Applied Research Foundation (Meso Foundation) increased its program expenditures to 86% of its budget, which is over 11 points higher than other highly rated charities. Alexandria, VA (PRWEB) June 30, 2014 The Mesothelioma Applied Research Foundation (Meso Foundation) announced that an audit of its 2013 financial statements confirmed an increase of program expenditures to 86% of its budget. Consequently, the amount spent on...

2014-06-30 23:15:02

After staying in the industry for quite some time, RezVera has developed natural remedies which are great at threating a wide variety of digesting problems. (PRWEB) June 30, 2014 After staying in the industry for quite some time, RezVera has developed natural remedies which are great at threating a wide variety of digesting problems. At least once in everyone’s life, there comes a time when they experience issues related to digestion, some of these including flatulence, bloating gasor,...

2014-06-30 23:13:33

The Mesothelioma Applied Research Foundation (Meso Foundation) announces the release of the new version of the page about its “Meet the Mesothelioma Experts” live broadcast series, which makes the recordings of its educational series user-friendly and easier to access. Alexandria, VA (PRWEB) June 30, 2014 The Mesothelioma Applied Research Foundation (Meso Foundation) announces the release of the new version of the page about its “Meet the Mesothelioma Experts” live broadcast...

2014-06-30 23:04:20

American Brain Tumor Association and American Association of Neuroscience Nurses releases pediatric nursing clinical guidelines for brain tumor patients. Chicago, IL (PRWEB) June 30, 2014 To meet the unique needs of pediatric brain tumor patients, the American Brain Tumor Association (ABTA) and the American Association of Neuroscience Nurses (AANN) created a clinical practice guideline (CPG) that specializes in the treatment of children with brain tumors. An estimated 4,300 children will...

2014-06-30 23:01:16

The Mesothelioma Applied Research Foundation (Meso Foundation) unveiled today its expanded Travel Grant program, which provides patients in need of financial help for travel expenses to consult with a specialist, or to participate in a clinical trial away from home. Alexandria, VA (PRWEB) June 30, 2014 The Mesothelioma Applied Research Foundation (Meso Foundation) announced today the expansion of its ‘Travel Grant’ program for mesothelioma patients. The program, which was created...

2014-06-30 14:44:43

Georgetown University Medical Center For a rare form of cancer called thymoma, researchers have discovered a single gene defining the difference between a fast-growing tumor requiring aggressive treatment and a slow-growing tumor that doesn't require extensive therapy. Thymoma is a cancer derived from the epithelial cells of the thymus, an organ critical to the lymphatic system where T-cells, or so-called "killer cells," mature. Very little is known about the role of the gene mutation...

2014-06-30 13:06:13

European Society for Medical Oncology ESMO 16 World GI Congress on Gastrointestinal Cancer The new combination agent TAS-102 is able to improve overall survival compared to placebo in patients whose metastatic colorectal cancer is refractory to standard therapies, researchers said at the ESMO 16th World Congress on Gastrointestinal Cancer in Barcelona. "Around 50% of patients with colorectal cancer develop metastases but eventually many of them do not respond to standard therapies,"...

2014-06-30 12:31:36

In the practice of Gynecologic Oncology, Hereditary Cancer Risk, and Women's Health TEANECK, N.J., June 30, 2014 /PRNewswire/ -- Holy Name Medical Center (HNMC) welcomes gynecologic oncologist, hereditary cancer risk and women's health specialists Sharyn N. Lewin, MD, FACS, and Phyllis Tarallo, DNP, DCC, both of whom will be members of the Holy Name Physician Network. Dr. Lewin is a board-certified gynecologic oncologist specializing in the diagnosis, treatment and management of...


Word of the Day
glogg
  • Scandinavian punch made of claret and aquavit with spices and raisins and orange peel and sugar.
This word comes from the Swedish 'glogg,' which is an alteration of 'glodgat,' mulled (wine).
Related